Linda Vona-Davis

Summary

Affiliation: West Virginia University
Country: USA

Publications

  1. ncbi Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, P O Box 9238, Morgantown, WV 26506, USA
    Curr Diabetes Rev 8:116-30. 2012
  2. ncbi Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia
    L Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506, USA
    J Surg Res 103:1-7. 2002
  3. ncbi Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
    L Vona-Davis
    Department of Surgery and Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506 9238, USA
    Obes Rev 8:395-408. 2007
  4. ncbi Expression of STAT3 and SOCS3 in pancreatic acinar cells
    Linda C Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506 9238, USA
    J Surg Res 127:14-20. 2005
  5. ncbi Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
    Linda Vona-Davis
    Department of Surgery and Mary Babb Randolph Cancer Center, West Virginia University, PO Box 9238, Morgantown, West Virginia 26506, USA
    Endocr Relat Cancer 14:189-206. 2007
  6. ncbi Triple-negative breast cancer and obesity in a rural Appalachian population
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, P O Box 9238, Morgantown, WV 26506, USA
    Cancer Epidemiol Biomarkers Prev 17:3319-24. 2008
  7. ncbi The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review
    Linda Vona-Davis
    Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Center of Excellence in Women s Health, P O Box 9238, Morgantown, WV 26506, USA
    J Womens Health (Larchmt) 18:883-93. 2009
  8. ncbi Angiogenesis, adipokines and breast cancer
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, United States
    Cytokine Growth Factor Rev 20:193-201. 2009
  9. ncbi COX-2 inhibition and cancer: experimental findings and clinical correlates
    Elizabeth Gail Roberts
    West Virginia University School of Medicine, Morgantown, USA
    W V Med J 100:96-101. 2004
  10. ncbi Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma
    David W McFadden
    Department of Surgery, Robert C Byrd Health Science Center, West Virginia University, P O Box 9238, Morgantown, WV 26506 9238, USA
    Am J Surg 186:552-5. 2003

Collaborators

Detail Information

Publications32

  1. ncbi Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, P O Box 9238, Morgantown, WV 26506, USA
    Curr Diabetes Rev 8:116-30. 2012
    ..These mechanistic considerations are consistent with metformin having high potential as a breast cancer chemopreventive and therapeutic agent...
  2. ncbi Effect of creatine monohydrate on cardiac function in a rat model of endotoxemia
    L Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506, USA
    J Surg Res 103:1-7. 2002
    ..This study was undertaken to investigate whether creatine (Cr) administered during perfusion could enhance myocardial protection and improve recovery of cardiac function in a rat model of endotoxemia...
  3. ncbi Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
    L Vona-Davis
    Department of Surgery and Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506 9238, USA
    Obes Rev 8:395-408. 2007
    ....
  4. ncbi Expression of STAT3 and SOCS3 in pancreatic acinar cells
    Linda C Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506 9238, USA
    J Surg Res 127:14-20. 2005
    ..Because activation of STAT3 and SOCS3 is also linked to cytokine stimulation, we tested TNFalpha and LPS, either alone or in combination with IL-1beta or IL-6 in an in vitro model using rat pancreatic acinar cells...
  5. ncbi Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
    Linda Vona-Davis
    Department of Surgery and Mary Babb Randolph Cancer Center, West Virginia University, PO Box 9238, Morgantown, West Virginia 26506, USA
    Endocr Relat Cancer 14:189-206. 2007
    ..In contrast, adiponectin, an endogenous insulin sensitizer, exerts a direct growth-inhibitory effect on tumor cells by downregulating cell proliferation and upregulating apoptosis, and also inhibits tumor-related angiogenesis...
  6. ncbi Triple-negative breast cancer and obesity in a rural Appalachian population
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, P O Box 9238, Morgantown, WV 26506, USA
    Cancer Epidemiol Biomarkers Prev 17:3319-24. 2008
    ....
  7. ncbi The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review
    Linda Vona-Davis
    Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University Center of Excellence in Women s Health, P O Box 9238, Morgantown, WV 26506, USA
    J Womens Health (Larchmt) 18:883-93. 2009
    ..Furthermore, we examine the association between obesity and breast cancer within socioeconomic disparities...
  8. ncbi Angiogenesis, adipokines and breast cancer
    Linda Vona-Davis
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, United States
    Cytokine Growth Factor Rev 20:193-201. 2009
    ....
  9. ncbi COX-2 inhibition and cancer: experimental findings and clinical correlates
    Elizabeth Gail Roberts
    West Virginia University School of Medicine, Morgantown, USA
    W V Med J 100:96-101. 2004
    ..Our study indicates that COX-2 inhibition reduces the growth of human breast and prostate cancer in vitro. Human studies are needed to evaluate the clinical utility of rofecoxib treatment in breast or prostate cancers...
  10. ncbi Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma
    David W McFadden
    Department of Surgery, Robert C Byrd Health Science Center, West Virginia University, P O Box 9238, Morgantown, WV 26506 9238, USA
    Am J Surg 186:552-5. 2003
    ..We hypothesized that KLH would be effective against Barrett's esophageal adenocarcinoma in an in vitro model...
  11. ncbi Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J
    Kristine Robinson
    Department of Surgery, West Virginia University, Morgantown, WV 26506, USA
    J Am Coll Surg 202:788-96. 2006
    ..We hypothesized that tumor necrosis factor (TNF)-alpha would induce STAT1 and STAT3, and PYY would attenuate their transcription factor binding...
  12. ncbi MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro
    Linda Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506-9238, USA
    J Surg Res 127:53-8. 2005
    ..Pro-apoptotic mechanisms prevail in the wild-type p53 cells. Further investigation is warranted to advance the clinical treatment of this devastating disease...
  13. ncbi Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro
    David W McFadden
    Department of Surgery, Robert C Byrd Health Science Center, West Virginia University, Morgantown, WV 26506, USA
    Am J Surg 188:516-9. 2004
    ..Adenocarcinoma of the esophagus usually arises from Barrett's esophagus. We hypothesized that treatment of Barrett's adenocarcinoma with PYY would result in decreased proliferation...
  14. ncbi In vitro effects of keyhole limpet hemocyanin in breast and pancreatic cancer in regards to cell growth, cytokine production, and apoptosis
    Dale R Riggs
    Department of Surgery, Robert C. Byrd Health Science Center, PO Box 9238, West Virginia University, Morgantown, WV 26506, USA
    Am J Surg 189:680-4. 2005
    ..CONCLUSIONS: KLH directly inhibits the growth of human breast and pancreas cancer in vitro by apoptotic and nonapoptotic mechanisms...
  15. ncbi Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis
    Linda Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, WV 26506, USA
    J Am Coll Surg 199:87-95. 2004
    ..Exposure to TNF-alpha activates transcription factors NF-kappaB, Smad3/4, and PPARalpha/gamma. PYY reduces this activation. Treatment with PYY may have therapeutic potential in improving AP...
  16. ncbi Interaction between menopausal status and obesity in affecting breast cancer risk
    David P Rose
    Department of Surgery, Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, Morgantown, WV 26506, USA
    Maturitas 66:33-8. 2010
    ....
  17. ncbi Influence of obesity on breast cancer receptor status and prognosis
    David P Rose
    Department of Surgery and Mary Babb Randolph Cancer Center, West Virginia University Robert C Byrd Health Sciences Center, Morgantown, WV 26506, USA
    Expert Rev Anticancer Ther 9:1091-101. 2009
    ..Weight control is important, not only to target breast cancer progression, but also to reduce the risk of nonbreast cancer mortality risk associated with excess adiposity...
  18. ncbi Proteomic analysis of SEG-1 human Barrett's-associated esophageal adenocarcinoma cells treated with keyhole limpet hemocyanin
    Linda Vona-Davis
    Department of Surgery, West Virginia University, Morgantown, WV 26506-9238, USA
    J Gastrointest Surg 8:1018-23. 2004
    ..The use of KLH as adjuvant or topical therapy for Barrett's adenocarcinoma provides a promising development in the treatment of this disease...
  19. ncbi Differential effects of leptin on cancer in vitro
    Ponnandai Somasundar
    Louis A Johnson VA Medical Center 26506, Morgantown, West Virginia 26506, USA
    J Surg Res 113:50-5. 2003
    ..Both leptin and leptin antagonism have potential efficacy in cancer therapy, based on cellular origin. Further studies are warranted and ongoing...
  20. ncbi Peptide YY reverses TNF-alpha induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells
    Irfan A Rizvi
    Department of Surgery, West Virginia University, Morgantown, West Virginia 26506 9238, USA
    J Surg Res 136:25-30. 2006
    ..We hypothesized that TNF-alpha would induce IRF-1 and p53 protein binding in pancreatic acinar cells and that PYY would attenuate the effect...
  21. ncbi Triple-negative breast cancer in West Virginia
    Jame Abraham
    Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, USA
    W V Med J 105:54-9. 2009
    ..Other factors such as obesity, diabetes, poverty and access to mammography screening could be influencing the poorer outcomes for women with breast cancer in West Virginia...
  22. ncbi Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer
    Ponnandai Somasundar
    Louis A. Johnson VA Medical Center, Clarksburg, West Virginia; Department of Surgery, West Virginia University, Morgantown, West Virginia, USA
    J Surg Res 126:199-203. 2005
    ..Further in vivo and human studies are needed to evaluate safety and clinical utility of this agent in patients with pancreatic cancer...
  23. ncbi Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms
    Ponnandai Somasundar
    Department of Surgery, Robert C. Byrd Health Science Center, West Virginia University, Morgantown, WV, USA
    Am J Surg 186:575-8. 2003
    ..The data suggest that leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms. Leptin antagonism may have potential efficacy in esophageal cancer therapy...
  24. ncbi PYY and the pancreas: inhibition of tumor growth and inflammation
    Linda Vona Davis
    Department of Surgery, West Virginia University, PO Box 9238, Morgantown, WV 26506, USA
    Peptides 28:334-8. 2007
    ..The present paper reviews our current findings with PYY and examines the therapeutic implications of its utility in treating inflammation and cancer...
  25. ncbi Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1)
    Linda Vona-Davis
    Department of Surgery, Robert C. Byrd Health Science Center, West Virginia University, Morgantown, West Virginia, USA
    J Surg Res 119:143-8. 2004
    ..Further in vivo and human studies are warranted to evaluate the safety and clinical utility of these agents in patients with all cancers of the esophagus...
  26. ncbi Leptin is a growth factor in cancer
    Ponnandai Somasundar
    West Virginia University, Department of Surgery, PO Box 9238, Morgantown, West Virginia 26506, USA
    J Surg Res 116:337-49. 2004
  27. ncbi Modulation of interleukin-6 in cardiac myoblasts during endotoxemia
    Linda Vona-Davis
    Department of Surgery, West Virginia University Morgantown, West Virginia 26506, USA
    J Surg Res 112:91-6. 2003
    ..CONCLUSIONS: In cardiac myoblasts, IL-6 is either enhanced or reduced depending on interactions between LPS and cytokine challenge. Enhanced nuclear translocation of NF-kappaB in response to LPS was evident in a myogenic cell line...
  28. ncbi Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization
    Ganga Prabhakar
    West Virginia University, Department of Surgery, Morgantown, WV 26506-9238, USA
    J Am Coll Surg 197:786-91. 2003
    ..CONCLUSIONS: PCr restores high-energy phosphates and attenuates metabolic stress during periods of myocardial ischemia in the rat. Preconditioning with PCr may serve as a useful adjunct to off-pump coronary revascularization...
  29. ncbi Factors influencing adherence to mammography screening guidelines in Appalachian women participating in a mobile mammography program
    Ami Vyas
    Department of Pharmaceutical Systems and Policy, School of Pharmacy, Robert C Byrd Health Sciences Center North, West Virginia University, Morgantown, WV 26506 9510, USA
    J Community Health 37:632-46. 2012
    ..Increasing adherence to mammography screening may require targeted, community-based educational interventions that precede and complement visits by the mobile mammography unit...
  30. ncbi The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression
    David P Rose
    Department of Surgery and Breast Cancer Research Program, Mary Babb Randolph Cancer Center, West Virginia University, PO Box 9238, Morgantown, West Virginia 26506, USA
    Endocr Relat Cancer 19:R225-41. 2012
    ..Understanding the various mechanisms by which insulin participates in breast cancer cell biology provides opportunities for novel approaches to treatment...
  31. ncbi In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin
    Dale R Riggs
    Department of Surgery, West Virginia University, PO Box 9238, Morgantown, 26506, USA
    J Surg Res 108:279-84. 2002
    ..Investigation into the efficacy and mechanism of response could directly lead to more effective treatment regimens for patients suffering from these diseases...
  32. ncbi Cardiac response to nitric oxide synthase inhibition using aminoguanidine in a rat model of endotoxemia
    Linda Vona-Davis
    Department of Surgery, West Virginia University, C Byrd Health Sciences Center, Morgantown 26506-9238, USA
    Shock 17:404-10. 2002
    ..We conclude that selective inhibition of iNOS and the reduction of NO production do not prevent cardiac dysfunction at an early stage in an acute model of endotoxemia...